SCHEDULE: Kanen Group Amends EGAIN Stake, Details Recent Share Sales

Kanen Wealth Management and affiliated funds updated their beneficial ownership in EGAIN Corp to 7.6%, disclosing recent sales by Philotimo Fund, LP.

Summary

• Amendment No. 4 to Schedule 13D has been re-filed by Kanen Wealth Management LLC and affiliated entities regarding their stake in EGAIN Corp, primarily to update transactions in securities.
• As of October 8, 2025, the reporting group, including Philotimo Fund, LP, Philotimo Focused Growth & Income Fund (PHLOX), Kanen Wealth Management LLC (KWM), and David Kanen, beneficially owns an aggregate of 2,047,683 shares.
• This aggregate ownership represents approximately 7.6% of EGAIN Corp's 26,867,067 outstanding common shares as of September 5, 2025.
• Philotimo Fund, LP sold a total of 641,160 shares of common stock between September 4, 2025, and October 8, 2025.
• The sale prices for Philotimo Fund, LP's transactions ranged from $6.3205 to $13.0630 per share.
• The shares purchased by Philotimo and PHLOX were acquired using working capital and customer funds, respectively, which may include margin loans.
• The aggregate purchase price for the 1,056,031 shares currently beneficially owned by Philotimo is approximately $7,977,132, and for the 734,187 shares by PHLOX is approximately $5,934,578.

Sentiment

Score: 5

Explanation: The filing is neutral as it primarily reports factual changes in beneficial ownership and past trading activity. While there were significant sales by one fund, the overall group maintains a substantial stake, preventing a strongly negative sentiment. It's a routine update for a Schedule 13D filer.

Positives

• The reporting group maintains a significant beneficial ownership stake of 7.6% in EGAIN Corp, indicating continued interest in the company.
• Philotimo Fund, LP realized sales at increasing prices, with some transactions occurring at over $13.00 per share, suggesting profitable exits on those specific sales.

Negatives

• Philotimo Fund, LP engaged in significant sales of common stock, totaling 641,160 shares over the past sixty days, which could be interpreted as a reduction in conviction or profit-taking.
• The sales occurred across a wide price range, including some at lower prices, indicating varied market conditions or a dynamic selling strategy during the period.

Risks

• Significant selling activity by a major beneficial owner could signal potential concerns about the company's future performance or valuation, potentially impacting investor sentiment.
• The reliance on margin loans for share purchases by the reporting persons introduces financial leverage risk for their investment portfolios.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance from EGAIN Corp or the reporting persons regarding the company's future performance or strategic direction, beyond the nature of their investment.

Industry Context

This filing reflects an institutional investor group's ongoing position and recent trading activity in EGAIN Corp. Such Schedule 13D/A filings are common for active investors who cross the 5% beneficial ownership threshold and subsequently amend their holdings. The sales by Philotimo Fund, LP could be part of a portfolio rebalancing strategy or a response to market conditions, rather than a direct commentary on EGAIN Corp's industry standing.

Stakeholder Impact

• Shareholders: The reported sales by Philotimo Fund, LP could create downward pressure on the stock price or signal a lack of confidence, potentially impacting other shareholders. Conversely, the group's continued significant ownership might be seen as a positive signal.
• Company Management: Management may need to consider the implications of a large shareholder group's trading activity, especially if it reflects a change in investment thesis.

Key Dates

Recommendation

The filing indicates significant selling activity by one of the Kanen group's funds (Philotimo Fund, LP) over the past sixty days, which could be interpreted as profit-taking or a reduction in conviction. However, the overall group still maintains a substantial 7.6% beneficial ownership in EGAIN Corp. Without further context on the reasons for the sales or the group's current investment thesis, a 'hold' recommendation is appropriate. Investors should monitor future filings and company performance for clearer directional signals, as the current information presents a mixed picture of continued significant ownership alongside recent divestment.

Keywords

EGAIN Corp, Schedule 13D/A, Beneficial Ownership, Philotimo Fund, Kanen Wealth Management, Share Sales, Institutional Investor, SEC Filing, Common Stock